MRI of Breast Tumor Initiating Cells Using the Extra Domain-B of Fibronectin Targeting Nanoparticles

Theranostics - Canada
doi 10.7150/thno.8343
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ivyspring International Publisher

Related search

Identifying and Targeting Tumor-Initiating Cells in the Treatment of Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2015English

Copper Oxide Nanoparticles Inhibit Pancreatic Tumor Growth Primarily by Targeting Tumor Initiating Cells

Scientific Reports
Multidisciplinary
2019English

Senescence Evasion by McF-7 Human Breast Tumor-Initiating Cells

Breast Cancer Research
Cancer ResearchOncology
2010English

Expression of Extra Domain a Fibronectin Sequence in Vascular Smooth Muscle Cells Is Phenotype Dependent

Journal of Cell Biology
MedicineCell Biology
1989English

Identification of Tumor-Initiating Cells in a P53-Null Mouse Model of Breast Cancer

Cancer Research
Cancer ResearchOncology
2008English

Aspirin Blocks Growth of Breast Tumor Cells and Tumor-Initiating Cells and Induces Reprogramming Factors of Mesenchymal to Epithelial Transition

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2015English

Characterisation and Radioimmunotherapy of L19-Sip, an Anti-Angiogenic Antibody Against the Extra Domain B of Fibronectin, in Colorectal Tumour Models

British Journal of Cancer
Cancer ResearchOncology
2007English

Functionalization of Iron Oxide Magnetic Nanoparticles With the Multivalent Pseudopeptide N6l for Breast Tumor Targeting

Journal of Nanomedicine & Nanotechnology
2015English

Lack of Fibronectin Extra Domain a Alternative Splicing Exacerbates Endothelial Dysfunction in Diabetes

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy